CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

Bradley D. Hunter, Matthew Lunning, Mazyar Shadman, Sairah Ahmed, Jeremy S. Abramson, Miguel-Angel Perales, Nausheen Ahmed, Abu-Sayeef Mirza, Iris Isufi, Matthew J. Frigault, Jennifer L. Crombie, David B. Miklos, Alberto Vasconcelos, Alessandro Crotta, David Bernasconi, Debasmita Roy, Eric Bleickardt, Marcelo C. Pasquini, Manali Kamdar

Open source

DOI
10.1016/j.jtct.2025.10.024
Published
2026-02
Container
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2025.10.024,
  title = {CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting},
  author = {Bradley D. Hunter and Matthew Lunning and Mazyar Shadman and Sairah Ahmed and Jeremy S. Abramson and Miguel-Angel Perales and Nausheen Ahmed and Abu-Sayeef Mirza and Iris Isufi and Matthew J. Frigault and Jennifer L. Crombie and David B. Miklos and Alberto Vasconcelos and Alessandro Crotta and David Bernasconi and Debasmita Roy and Eric Bleickardt and Marcelo C. Pasquini and Manali Kamdar},
  year = {2026},
  journal = {Transplantation and Cellular Therapy},
  doi = {10.1016/j.jtct.2025.10.024},
  url = {https://doi.org/10.1016/j.jtct.2025.10.024}
}

RIS

TY  - JOUR
TI  - CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting
AU  - Bradley D. Hunter
AU  - Matthew Lunning
AU  - Mazyar Shadman
AU  - Sairah Ahmed
AU  - Jeremy S. Abramson
AU  - Miguel-Angel Perales
AU  - Nausheen Ahmed
AU  - Abu-Sayeef Mirza
AU  - Iris Isufi
AU  - Matthew J. Frigault
AU  - Jennifer L. Crombie
AU  - David B. Miklos
AU  - Alberto Vasconcelos
AU  - Alessandro Crotta
AU  - David Bernasconi
AU  - Debasmita Roy
AU  - Eric Bleickardt
AU  - Marcelo C. Pasquini
AU  - Manali Kamdar
PY  - 2026
JO  - Transplantation and Cellular Therapy
DO  - 10.1016/j.jtct.2025.10.024
UR  - https://doi.org/10.1016/j.jtct.2025.10.024
ER  - 

APA

Hunter, B. D., Lunning, M., Shadman, M., Ahmed, S., Abramson, J. S., Perales, M., Ahmed, N., Mirza, A., Isufi, I., Frigault, M. J., Crombie, J. L., Miklos, D. B., Vasconcelos, A., Crotta, A., Bernasconi, D., Roy, D., Bleickardt, E., Pasquini, M. C., & Kamdar, M. (2026). CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2025.10.024

Source records